Allarity Therapeutics, Inc. (ALLR)
0.96
-0.02
(-1.63%)
USD |
NASDAQ |
Nov 06, 10:21
Allarity Therapeutics Net Income (Quarterly) : -3.405M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.405M |
| March 31, 2026 | -2.75M |
| December 31, 2025 | -3.373M |
| September 30, 2025 | -2.806M |
| June 30, 2025 | -2.32M |
| March 31, 2025 | -2.732M |
| December 31, 2024 | -7.453M |
| September 30, 2024 | -11.59M |
| June 30, 2024 | -1.629M |
| March 31, 2024 | -3.843M |
| December 31, 2023 | -1.722M |
| September 30, 2023 | -4.447M |
| Date | Value |
|---|---|
| June 30, 2023 | -2.38M |
| March 31, 2023 | -3.352M |
| December 31, 2022 | -2.838M |
| September 30, 2022 | -5.037M |
| June 30, 2022 | -5.103M |
| March 31, 2022 | -3.08M |
| December 31, 2021 | -16.82M |
| September 30, 2021 | -1.351M |
| June 30, 2021 | -5.396M |
| March 31, 2021 | -3.085M |
| September 30, 2020 | -0.96M |
| June 30, 2020 | -1.962M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 53.52M |
| Alnylam Pharmaceuticals, Inc. | 2.167B |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.405M |
| EPS Diluted (Quarterly) | -0.214 |
| Enterprise Value | 10.83M |
| Earnings Yield | -81.92% |
| Normalized Earnings Yield | -81.32 |